PRNP and pancreatic ductal adenocarcinoma: Indeed, Chieng and Say (2015) found that overexpression of PrPC in a colon adenocarcinoma cell line increased invasiveness, whilst a study of pancreatic ductal adenocarcinoma patients reported that PrPC-positive tumours were associated with reduced survival time from diagnosis (Sy et al., 2011).